Results 201 to 210 of about 61,613 (221)

Irinotecan

Reactions Weekly, 2016
openaire   +2 more sources

Phase II/III Study of Second-Line Chemotherapy Comparing Irinotecan-Alone With S-1 Plus Irinotecan in Advanced Gastric Cancer Refractory to First-Line Treatment With S-1 (JACCRO GC-05)

Annals of Oncology, 2015
M Kochi, Y Kakeji, N Matsuhashi
exaly  

Irinotecan Combined With Fluorouracil Compared With Fluorouracil Alone as First-Line Treatment for Metastatic Colorectal Cancer: A Multicentre Randomised Trial

Lancet, The, 2000
David Cunningham, T Iveson, G Gruia
exaly  

Efficacy of FOLFIRI-3 (Irinotecan D1,D3 Combined With LV5-FU) or Other Irinotecan-Based Regimens in Oxaliplatin-Pretreated Metastatic Colorectal Cancer in the GERCOR OPTIMOX1 Study

Annals of Oncology, 2009
François-Clément Bidard, C Louvet, G Lledo   +2 more
exaly  

Irinotecan in Combination With 5-Fluorouracil and Folinic Acid or With Cisplatin in Patients With Advanced Gastric or Esophageal-Gastric Junction Adenocarcinoma: Results of a Randomized Phase II Study

Annals of Oncology, 2004
Johannes Bükki, V Gorbunova, C Peschel
exaly  

Irinotecan

Reactions Weekly, 2022
openaire   +1 more source

A Randomized Phase II Study of PEP02 (MM-398), Irinotecan or Docetaxel as a Second-Line Therapy in Patients With Locally Advanced or Metastatic Gastric or Gastro-Oesophageal Junction Adenocarcinoma

Annals of Oncology, 2013
David Cunningham, Josep Tabernero Caturla, S R Park   +2 more
exaly  

Irinotecan

Reactions Weekly, 2003
openaire   +3 more sources

Multicentre Phase II Study and Pharmacokinetic Analysis of Irinotecan in Chemotherapy-Naïve Patients With Glioblastoma

Annals of Oncology, 2003
V Boige, E Raymond, M Frénay
exaly  

A Phase I and Pharmacokinetic Study of Irinotecan in Patients With Hepatic or Renal Dysfunction or With Prior Pelvic Radiation: CALGB 9863

Annals of Oncology, 2003
G Fleming, C G Leichman, M J Ratain
exaly